NEW YORK (GenomeWeb News) – Next-generation sequencing instrument firm GnuBio said on Wednesday it is moving to a new 11,000-square-foot space to facilitate its transition to commercialization mode.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.